Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral recombinant B subunit/bacterial cholera vaccine for prevention of non-cholera infectious diarrhea in children
ChiCTR2600116587Phase 4Not yet recruiting
- Sponsor
- Jiangsu Provincial Center for Disease Control and Prevention
- Start
- Jan 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of cholera vaccine (oral, inactivated) in gastroenteritis (2 arms), sponsored by Jiangsu Provincial Center for Disease Control and Prevention. Primary endpoint: Incidence of infectious diarrhea (excluding Vibrio cholerae). Planned start Jan 2026; status: not yet recruiting.
02
Drugs
cholera vaccine (oral, inactivated)
03
Conditions
gastroenteritis
Beyond the preview
Go deeper on ChiCTR2600116587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600116587.